NSE: THYROCARE | BSE: 539871

Strong Performer, Getting Expensive

Download real time

1564.00 73.40 (4.92%)

New 52W High today

714.3K NSE+BSE Volume

NSE 14 Nov, 2025 3:31 PM (IST)

8,297.6

Market Cap

High in industry

0.3

Beta 1Year

Very Low volatility

Thyrocare Technologies Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for THYROCARE, BSE:539871 Thyrocare Technologies Ltd.

Thyrocare Technologies Ltd.

16 Aug 2016

1564.00

4.92%

Pick of the Week - Thyrocare Technologies Ltd

Buy: Thyrocare Technologies Ltd.

HDFC Securities

BUY Thyrocare Technologies Ltd on Declines Between Rs. 520 - Rs. 490 for the target of Rs. 625 - Rs. 710

Thyrocare Technologies Ltd. has gained 18.11% in the last 1 Week

Thyrocare Technologies Ltd.

27 Apr 2016

1564.00

4.92%

Thyrocare Technologies IPO Note

Thyrocare Technologies Ltd.

BOB Capital Markets Ltd.

The company is a provider of diagnostic and related healthcare tests and services in India and is specialised in preventive and wellness segment of the diagnostics industry which has broader scope to grow with improving life style...

Promoters unpledged 14.16% of shares in last quarter. Total pledge stands at 85.84% of promoter holdings

Thyrocare Technologies Ltd.

27 Apr 2016

1564.00

4.92%

Thyrocare IPO note 27Apr2016

Thyrocare Technologies Ltd.

Phillip Capital

chains. It has a leadership position in (the fastest growing and highest valueadded) diagnosticserviceofferingsinwellnessandpreventivecarethismakesitanindustryleader inprofitability.Weexpectittodeliverrevenue/PATCAGRof25%/29%overFY1518.Atthe...

Promoters unpledged 14.16% of shares in last quarter. Total pledge stands at 85.84% of promoter holdings

Thyrocare Technologies Ltd.

27 Apr 2016

1564.00

4.92%

IPO Note - Thyrocare Technologies ltd

IPO Note: Thyrocare Technologies Ltd.

Aditya Birla Money Limited

Strong operating performance and asset light model leading to high returns: The franchise model of the company has helped it to minimize its capital expenditure leading to higher returns on equity as well as return on capital employed. TTL's sales...

Thyrocare Technologies Ltd. has gained 23.97% in the last 1 Month

Is Thyrocare Technologies Ltd. worth buying?

174 Votes:

Buy 77.01%

Sell 12.07%

Hold 10.92%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf